Timber Hill’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-5,855
Closed -$619K 1159
2017
Q1
$575K Buy
+5,855
New +$558K ﹤0.01% 1399
2016
Q2
Sell
-9,653
Closed -$735K 2142
2016
Q1
$690K Buy
+9,653
New +$647K ﹤0.01% 1431
2015
Q2
Sell
-9,178
Closed -$678K 2498
2015
Q1
$705K Sell
9,178
-12,906
-58% -$924K ﹤0.01% 1622
2014
Q4
$1.48M Sell
22,084
-1,657
-7% -$105K 0.01% 1193
2014
Q3
$1.44M Buy
23,741
+4,197
+21% +$259K 0.01% 1346
2014
Q2
$1.15M Sell
19,544
-14,690
-43% -$860K 0.01% 1576
2014
Q1
$1.98M Buy
34,234
+17,165
+101% +$920K 0.01% 1171
2013
Q4
$914K Buy
+17,069
New +$1.01M ﹤0.01% 1900

Other funds holding DGX

Timber Hill's DGX Position: Q2 2017 in Review

Timber Hill sold out of Quest Diagnostics (DGX) in Q2 2017, closing a stake of 5,855 shares — an estimated $619K sold.

Timber Hill first reported a position in DGX in Q4 2013 and held it in 8 quarters. The position peaked at $1.98M in Q1 2014. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Timber Hill reported no remaining Quest Diagnostics position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 5,855 Quest Diagnostics shares in Q2 2017, an estimated $619K.
  • Timber Hill first reported a position in Quest Diagnostics in Q4 2013 and held it in 8 quarters.
  • Timber Hill's Quest Diagnostics position peaked at $1.98M in Q1 2014.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.